Clinical Trial Update: AZD8683 Multiple Dose Study in Healthy Volunteers and Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 1]

View source ↗

Summary

AZD8683 is being studied in a Phase 1 multiple-dose trial involving healthy volunteers and COPD patients. The study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• AZD8683

Snippet

Sponsor: AstraZeneca | Conditions: COPD | Phase 1 | Status: TERMINATED